http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016202831-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcbabb591dd6228286720f97f5221b94 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24 |
filingDate | 2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3909b18e3e26c2419ba6112c0367463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e153a32344d37da43f4dba683ea4feb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db5a5ccc3c7c1dbef20372e5707ae53f |
publicationDate | 2016-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2016202831-A1 |
titleOfInvention | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
abstract | Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may 5 include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. 7699354_1 (GHMatters) P103018.AU |
priorityDate | 2015-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.